The Kashmir HorizonOpinion

Bioinformatics Reshapes Discovery

Why universities and institutions must prioritise the science that gives meaning to modern biology  A single human genome ...
biopharmaapac

Metabolon Launches AI-Enabled Splash & Ripple to Accelerate Metabolomics-Driven Drug Discovery

Metabolon, Inc., the global leader in metabolomics solutions advancing life sciences research, diagnostics, therapeutics, and precision medicine, announced Splash & Ripple, a new bioinformatics ...
BIOENGINEER

Bioinformatics study links two downregulated genes to tendinopathy biomarkers

PTCHD1 and NEURL1 were significantly downregulated in tendinopathy samples, while a gene-based diagnostic model achieved an ...

Metabolon, Inc.: Metabolon Announces New Bioinformatics Application to Translate Metabolomic Biomarkers into Actionable Multiomic Hypotheses

Metabolon Announces New Bioinformatics Application to Translate Metabolomic Biomarkers into Actionable Multiomic Hypotheses New bioinformatics application combines curated metabolite-protein knowledge ...
The Manila Times

Metabolon Announces New Bioinformatics Application to Translate Metabolomic Biomarkers into Actionable Multiomic Hypotheses

New bioinformatics application combines curated metabolite-protein knowledge, advanced network algorithms, interactive exploration, and optional AI interpretation to generate clearer mechanistic hypot ...

Artificial Intelligence in Genomics Market - Global Forecast to 2036 | Market to Reach USD 19.96 Billion at 26.5% CAGR, Fueled by Precision Medicine and AI-Driven Drug Discovery

Software, genome sequencing, drug discovery and cloud platforms lead adoption, while precision medicine, diagnostics and AI-enabled services create new opportunities.Dublin, Oct. 19, 2026 (GLOBE ...